Pharmaceutical Digital Health Innovation Index – Introduction

In 2021, Galen Growth developed the Pharmaceutical Digital Health Innovation Index as a method of evaluating the Digital Health portfolios of pharmaceutical and biotech companies. This 2022 edition updates the Index based on the announcement of new partnerships and the growth of portfolio maturity for each pharma and biotech. To rank within the top 25, companies need to have a global presence and at least 11 publicly announced partnerships with private Digital Health ventures.

Looking at the 25 top performers in Digital Health, our analysis focuses on two critical aspects: first, the strategic fit of the portfolio to the pharmaceutical; second, the strength of the venture portfolio.

Insights from the Pharmaceutical Digital Health Innovation Index

  • Integration of Digital Health by pharmaceuticals is beginning to gain focus, with the average maturity of new pharmaceutical portfolio ventures in 2022 exceeding the average total portfolio maturity.
  • Digital Health solutions for Research and Clinical Trials dominate pharmaceutical portfolios, with 25% of the smallest portfolios (1 to 2 ventures) including ventures in the Research Solutions cluster and 14% including ventures in the Clinical Trials cluster. By the time the portfolio exceeds a volume of 30 ventures, the following clusters & categories are included in 100% of the portfolios: Teleconsultation, Disease Management, Remote Monitoring Devices, and Clinical Trials.
  • The Pareto diagram of the number of venture partnerships across all pharmaceuticals has flattened slightly during 2022. Last year, only the top 30 pharmaceuticals had developed more than 5 partnerships, whereas there are 40 pharmaceuticals now crossing the 5 partnerships line.

Explore the Data behind the Report

If you want to explore the data behind the report, check out the full list of the top 25 pharmaceutical companies.

If you aren’t already a user of HealthTech Alpha, sign up for a free trial to learn more about our platform.

Source of Data

HealthTech Alpha, Galen Growth’s proprietary on-demand platform, is the data source for this report. HealthTech Alpha contains more than 200 million data points and hence is the leading Digital Health intelligence and analytics platform! Moreover, its coverage exceeds 12,000 Digital Health ventures globally. To find out more about our data, visit https://www.healthtechalpha.com/, or visit https://www.galengrowth.com/research for our reports.

Our Mission

Founded by HealthTech innovators, Galen Growth solves global healthcare system pain points and to create significant financial and social values. To find out more, visit https://www.galengrowth.com/

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

Free

BASIC

  • Download the report headlines
  • Access to limited data in HealthTech Alpha
Free
View
Recommended

PRO

  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Pro
Custom Solution

Enterprise

  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024

Overview

Category

Stage

Total Funding

GGA Score

powered by